Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer

Back

13th World Congress on Biofuels and Bioenergy

Vienna, Austria

Reem Swidah

University of Manchester, UK

Title: Biobutanol production from a Saccharomyces cerevisiae

Biography

Biography: Reem Swidah

Abstract

Biobutanol represents a second generation biofuel, which can be produced naturally by a number of microorganisms. This alcohol has a number of significant advantages over bioethanol in terms of its physical properties as a fuel, but production systems suffer from various drawbacks. Therefore, we sought to transplant an entire butanol production pathway (the ABE pathway) into a Saccharomyces cerevisiae strain. However, this pathway was incapable of generating reasonable yields of butanol without further metabolic alteration to channel carbon towards the substrate of butanol production, acetyl CoA. For instance, the major alcohol dehydrogenase, ADH1, was deleted and two enzymes involved in acetyl-CoA biosynthesis were overexpressed to give strains capable of producing 300 mg/L butanol. Surprisingly, deletion of the ADH1 gene alone is sufficient to produce 40 mg/L butanol from an endogenous pathway. Previously, this endogenous butanol production pathway was characterized and proposed to derive from the mitochondrial catabolism of threonine via multiple leucine biosynthetic genes and the conversion of 2-ketovalerate to butanol. Therefore, the endogenous butanol production pathway is characterized further and we suggest that the endogenous route for butanol synthesis does not use the pathway previously proposed via Leucine metabolic enzymes. This work therefore makes use of synthetic biology and metabolic engineering to effectively set the scene for an initiative towards higher yields of butanol in yeast via concerted interventions in both the endogenous and exogenous pathways.